Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Montefiore, widely recognised as Montefiore Einstein, stands as a premier academic health system headquartered in the US, with extensive operations across the New York metropolitan area, notably the Bronx and Westchester. With a rich legacy tracing back to Montefiore Hospital in 1905 and the Albert Einstein College of Medicine in 1955, it has evolved into one of the nation's leading institutions in healthcare.
Operating within the dynamic academic medicine and healthcare industry, Montefiore Einstein is renowned for its comprehensive patient care, groundbreaking medical research, and advanced health education. Its core services span numerous specialties, offering pioneering treatments and compassionate support to diverse communities. As a major provider of medical services, Montefiore is instrumental in shaping future healthcare advancements and delivering exceptional patient outcomes.
+4 vs industry average
Montefiore’s score of 36 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Montefiore, a US-based organisation in the Medical, precision and optical instruments, watches and clocks industry, reported total emissions of approximately 4.5 million kg CO2e in 2023. This comprised about 1.2 million kg CO2e from Scope 1 emissions, 800,000 kg CO2e from Scope 2 emissions, and 2.5 million kg CO2e from Scope 3 emissions. In the previous year, 2022, their total emissions were approximately 4.3 million kg CO2e, with around 1.15 million kg CO2e from Scope 1, 750,000 kg CO2e from Scope 2, and 2.4 million kg CO2e from Scope 3.
Montefiore has committed to achieving net-zero emissions by 2050 across all scopes. Additionally, as a signatory to the U.S. Department of Health and Human Services (HHS) climate pledge initiative, the organisation aims to reduce its total emissions by 50% by 2030, using 2023 as the base year.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more